CVR number 41532580
Industry 46.9000 Non-specialised wholesale trade

Disruptive Bio Trading ApS

 

Quicksearch
from your own companies
Analyst: XBRLDenmark
Loading...

Loading...

Loading...

Loading...

Loading...

Loading...

Loading...
Bankruptcy Risk 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  0.0% 0.0% 6.9% 3.4% 2.8%  
Credit score (0-100)  0 0 33 53 58  
Credit rating  N/A N/A BBB BBB BBB  
Credit limit (mDKK)  0.0 0.0 0.0 0.0 0.0  
How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (mDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  0 0 57 100 32  
Gross profit  0.0 0.0 3.0 14.9 4.0  
EBITDA  0.0 0.0 1.3 10.4 0.6  
EBIT  0.0 0.0 1.3 10.4 0.5  
Pre-tax profit (PTP)  0.0 0.0 1.2 10.2 0.4  
Net earnings  0.0 0.0 1.0 8.0 0.3  
Pre-tax profit without non-rec. items  0.0 0.0 1.2 10.2 0.4  
 
See the entire income statement

Balance sheet (mDKK) 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Tangible assets total  0.0 0.0 0.0 0.2 0.4  
Shareholders equity total  0.0 0.0 1.0 8.8 1.1  
Interest-bearing liabilities  0.0 0.0 0.1 0.0 3.8  
Balance sheet total (assets)  0.0 0.0 9.0 18.9 7.7  
Net Debt  0.0 0.0 -1.9 -0.5 2.2  
 
See the entire balance sheet

Volume 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales  0 0 57 100 32  
Net sales growth  0.0% 0.0% 0.0% 74.2% -68.1%  
Gross profit  0.0 0.0 3.0 14.9 4.0  
Gross profit growth  0.0% 0.0% 0.0% 393.8% -73.1%  
Employees  0 0 3 5 4  
Employee growth %  0.0% 0.0% 0.0% 66.7% -20.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  0 0 9 19 8  
Balance sheet change%  0.0% 0.0% 0.0% 108.8% -59.3%  
Added value  0.0 0.0 1.3 10.4 0.6  
Added value %  0.0% 0.0% 2.3% 10.4% 1.7%  
Investments  0 0 0 0 0  
Net sales trend  0.0 0.0 0.0 1.0 -1.0  
EBIT trend  0.0 0.0 1.0 2.0 3.0  

Profitability 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 2.3% 10.4% 1.7%  
EBIT %  0.0% 0.0% 2.3% 10.4% 1.7%  
EBIT to gross profit (%)  0.0% 0.0% 42.9% 70.1% 13.4%  
Net Earnings %  0.0% 0.0% 1.7% 8.0% 1.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 1.7% 8.0% 1.1%  
Pre tax profit less extraordinaries %  0.0% 0.0% 2.2% 10.2% 1.4%  
ROA %  0.0% 0.0% 14.4% 75.0% 4.3%  
ROI %  0.0% 0.0% 118.2% 210.8% 8.3%  
ROE %  0.0% 0.0% 96.0% 163.1% 6.6%  

Solidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  0.0% 0.0% 11.1% 46.5% 14.3%  
Relative indebtedness %  0.0% 0.0% 14.0% 10.1% 20.6%  
Relative net indebtedness %  0.0% 0.0% 10.6% 9.6% 15.5%  
Net int. bear. debt to EBITDA, %  0.0% 0.0% -145.0% -4.7% 400.7%  
Gearing %  0.0% 0.0% 10.1% 0.5% 350.2%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 0.0% 137.5% 315.6% 7.2%  

Liquidity 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  0.0 0.0 1.1 1.8 1.1  
Current Ratio  0.0 0.0 1.1 1.8 1.1  
Cash and cash equivalent  0.0 0.0 2.0 0.5 1.6  

Capital use efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 42.8 53.4 39.3  
Trade creditors turnover (days)  0.0 0.0 1,083.4 327.5 442.2  
Current assets / Net sales %  0.0% 0.0% 15.5% 18.6% 22.8%  
Net working capital  0.0 0.0 0.8 8.5 0.7  
Net working capital %  0.0% 0.0% 1.4% 8.5% 2.2%  

Employee efficiency 
2019
N/A
2020
N/A
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 19 20 8  
Added value / employee  0 0 0 2 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 0 2 0  
EBIT / employee  0 0 0 2 0  
Net earnings / employee  0 0 0 2 0